Cargando…

Potential Effectiveness of Chinese Patent Medicine Tongxinluo Capsule for Secondary Prevention After Acute Myocardial Infarction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Background: Chinese patent medicine Tongxinluo capsule (TXL) is commonly used for cardio-cerebrovascular diseases. Previous research had demonstrated that TXL exhibited great clinical effects on the treatment of acute myocardial infarction (AMI), however there is a lack of systematic review. The pur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Min, Li, Chengyu, Chen, Shiqi, Sun, Yang, Hu, Jiayuan, Zhao, Chen, Qiu, Ruijin, Zhang, Xiaoyu, Zhang, Qin, Tian, Guihua, Shang, Hongcai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085586/ https://www.ncbi.nlm.nih.gov/pubmed/30123126 http://dx.doi.org/10.3389/fphar.2018.00830

Ejemplares similares

Therapeutic Effects of Wenxin Keli in Cardiovascular Diseases: An Experimental and Mechanism Overview
por: Tian, Guihua, et al.
Publicado: (2018)

Development of a core outcome set (COS) and selecting outcome measurement instruments (OMIs) for non-valvular atrial fibrillation in traditional Chinese medicine clinical trials: study protocol
por: Qiu, Ruijin, et al.
Publicado: (2018)

Systematic Review of Tongxinluo Capsule on the Therapeutic Effect and Hemorheology of Patients with Transient Ischemic Attack
por: Yang, Peng, et al.
Publicado: (2021)

Chinese Patent Medicine Tongxinluo Capsule for Hypertension: A Systematic Review of Randomised Controlled Trials
por: Wang, Jie, et al.
Publicado: (2014)

Problems with the outcome measures in randomized controlled trials of traditional Chinese medicine in treating chronic heart failure caused by coronary heart disease: a systematic review
por: Hu, Jiayuan, et al.
Publicado: (2021)

Efficacy and Safety of Tongxinluo Capsule as Adjunctive Treatment for Unstable Angina Pectoris: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Li, Pengqi, et al.
Publicado: (2021)

Initiate Danhong Injection before or after percutaneous coronary intervention for microvascular obstruction in ST-elevation myocardial infarction (DIRECTION): study protocol for a randomized controlled trial
por: Zhang, Xiaoyu, et al.
Publicado: (2020)

Tongxinluo May Alleviate Inflammation and Improve the Stability of Atherosclerotic Plaques by Changing the Intestinal Flora
por: Qi, Yan, et al.
Publicado: (2022)

Traditional Chinese Medication Tongxinluo Attenuates Lipidosis in Ox-LDL-Stimulated Macrophages by Enhancing Beclin-1-Induced Autophagy
por: Chen, Yifei, et al.
Publicado: (2021)

Core Outcome Set for Clinical Trials of COVID-19 Based on Traditional Chinese and Western Medicine
por: Qiu, Ruijin, et al.
Publicado: (2020)

Development of a core outcome set for myocardial infarction in clinical trials of traditional Chinese medicine: a study protocol
por: Qiu, Ruijin, et al.
Publicado: (2019)

Tongxinluo Attenuates Myocardiac Fibrosis after Acute Myocardial Infarction in Rats via Inhibition of Endothelial-to-Mesenchymal Transition
por: Yin, Yujie, et al.
Publicado: (2019)

Traditional Chinese Medicine for Bradyarrhythmia: Evidence and Potential Mechanisms
por: Liu, Shuo, et al.
Publicado: (2018)

Tongxinluo Capsule Combined with Atorvastatin for Coronary Heart Disease: A Systematic Review and Meta-Analysis
por: Liu, Qiao, et al.
Publicado: (2021)

Tongxinluo capsule in combination with conventional therapies for stable angina pectoris: A meta-analysis and systematic review
por: Feng, Ruli, et al.
Publicado: (2023)

Cost-Effectiveness of Alirocumab for the Secondary Prevention of Cardiovascular Events after Myocardial Infarction in the Chinese Setting
por: Liang, Zhe, et al.
Publicado: (2021)

Inhibition of miR-128-3p by Tongxinluo Protects Human Cardiomyocytes from Ischemia/reperfusion Injury via Upregulation of p70s6k1/p-p70s6k1
por: Chen, Gui-hao, et al.
Publicado: (2017)

Efficacy and Safety of NaoShuanTong Capsule in the Treatment of Ischemic Stroke: A Meta-Analysis
por: Zhang, Hanlai, et al.
Publicado: (2019)

Tongxinluo Improves Cardiac Function and Ameliorates Ventricular Remodeling in Mice Model of Myocardial Infarction through Enhancing Angiogenesis
por: Bai, Wen-Wu, et al.
Publicado: (2013)

China Tongxinluo Study for myocardial protection in patients with Acute Myocardial Infarction (CTS-AMI): Rationale and design of a randomized, double-blind, placebo-controlled, multicenter clinical trial
por: Xu, Yi, et al.
Publicado: (2020)

Cardiac Microvascular Barrier Function Mediates the Protection of Tongxinluo against Myocardial Ischemia/Reperfusion Injury
por: Qi, Kang, et al.
Publicado: (2015)

Developing a core outcome set for assessing clinical safety outcomes of cardiovascular diseases in clinical trials of integrated traditional Chinese medicine and Western medicine: study protocol
por: Qiu, Ruijin, et al.
Publicado: (2022)

Experimental evidence and network pharmacology-based analysis reveal the molecular mechanism of Tongxinluo capsule administered in coronary heart diseases
por: Li, Guode, et al.
Publicado: (2020)

Post-myocardial infarction fibrosis: Pathophysiology, examination, and intervention
por: Yin, Xiaoying, et al.
Publicado: (2023)

Chinese Patent Medicine Shufeng Jiedu Capsules as an Adjuvant Therapy for Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

Naoxin’an capsules protect brain function and structure in patients with vascular cognitive impairment
por: Lu, Hui, et al.
Publicado: (2023)

The Role of Autophagy in Acute Myocardial Infarction
por: Wu, Du, et al.
Publicado: (2019)

Carotid artery plaque intervention with Tongxinluo capsule (CAPITAL): A multicenter randomized double-blind parallel-group placebo-controlled study
por: Zhang, Mei, et al.
Publicado: (2019)

Inhibiting leukocyte‐endothelial cell interactions by Chinese medicine Tongxinluo capsule alleviates no‐reflow after arterial recanalization in ischemic stroke
por: Liu, Shen, et al.
Publicado: (2023)

Tongxinluo Enhances Neurogenesis and Angiogenesis in Peri-Infarct Area and Subventricular Zone and Promotes Functional Recovery after Focal Cerebral Ischemic Infarction in Hypertensive Rats
por: Chen, Li, et al.
Publicado: (2016)

The circRNA-miRNA/RBP regulatory network in myocardial infarction
por: Zhang, Lei, et al.
Publicado: (2022)

Tongxinluo promotes axonal plasticity and functional recovery after stroke
por: Wang, Xiaoting, et al.
Publicado: (2020)

Secondary Prevention Medical Therapy and Outcomes in Patients With Myocardial Infarction With Non-Obstructive Coronary Artery Disease
por: Paolisso, Pasquale, et al.
Publicado: (2020)

Predictive value of myocardial strain on myocardial infarction size by cardiac magnetic resonance imaging in ST-segment elevation myocardial infarction with preserved left ventricular ejection fraction
por: Wang, Qiang, et al.
Publicado: (2022)

Treatment options of traditional Chinese patent medicines for dyslipidemia in patients with prediabetes: A systematic review and network meta-analysis
por: Jiang, Li, et al.
Publicado: (2022)

Lcz696 Alleviates Myocardial Fibrosis After Myocardial Infarction Through the sFRP-1/Wnt/β-Catenin Signaling Pathway
por: Liu, Jing, et al.
Publicado: (2021)

Resveratrol Attenuate Myocardial Injury by Inhibiting Ferroptosis Via Inducing KAT5/GPX4 in Myocardial Infarction
por: Liu, Jing, et al.
Publicado: (2022)

Xuanfei Pingchuan Capsules Ameliorate Autophagy in Human Bronchial Epithelial Cells by Inhibiting p38 Phosphorylation
por: Xue, Xiaoming, et al.
Publicado: (2021)

To Investigate the Clinical Efficacy and Potential Mechanism of Tongxinluo Capsules in Preventing Coronary Restenosis Based on Meta-Analysis and Network Pharmacology Analysis
por: Wei, Wen-Xin, et al.
Publicado: (2023)

A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Study of the Effects of Tongxinluo Capsules in Acute Coronary Syndrome Patients with High On-Treatment Platelet Reactivity
por: Zhang, Lei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_k4tfpma5d192tu2bu10nqme2c3